176 related articles for article (PubMed ID: 9925962)
1. Effect of interleukin-3, interleukin 5 and hyaluronic acid on cultured eosinophils derived from human umbilical cord blood mononuclear cells.
Ohashi H; Takei M; Ide Y; Ishii H; Kita H; Gleich GJ; Ishikawa M; Fukamachi H
Int Arch Allergy Immunol; 1999 Jan; 118(1):44-50. PubMed ID: 9925962
[TBL] [Abstract][Full Text] [Related]
2. Regulatory effect of cytokines on eosinophil degranulation.
Fujisawa T; Abu-Ghazaleh R; Kita H; Sanderson CJ; Gleich GJ
J Immunol; 1990 Jan; 144(2):642-6. PubMed ID: 2104901
[TBL] [Abstract][Full Text] [Related]
3. Release of granule proteins from eosinophils cultured with IL-5.
Kita H; Weiler DA; Abu-Ghazaleh R; Sanderson CJ; Gleich GJ
J Immunol; 1992 Jul; 149(2):629-35. PubMed ID: 1624806
[TBL] [Abstract][Full Text] [Related]
4. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils.
El-Shazly A; Masuyama K; Nakano K; Eura M; Samejima Y; Ishikawa T
Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():55-8. PubMed ID: 9758899
[TBL] [Abstract][Full Text] [Related]
5. Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate.
Boyce JA; Friend D; Matsumoto R; Austen KF; Owen WF
J Exp Med; 1995 Jul; 182(1):49-57. PubMed ID: 7540656
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of ketotifen on eotaxin-dependent activation of eosinophils: consequences for allergic eye diseases.
Woerly G; Loiseau S; Loyens M; Schoch C; Capron M
Allergy; 2003 May; 58(5):397-406. PubMed ID: 12752326
[TBL] [Abstract][Full Text] [Related]
7. Differentiation stages of eosinophils characterized by hyaluronic acid binding via CD44 and responsiveness to stimuli.
Watanabe Y; Hashizume M; Kataoka S; Hamaguchi E; Morimoto N; Tsuru S; Katoh S; Miyake K; Matsushima K; Tominaga M; Kurashige T; Fujimoto S; Kincade PW; Tominaga A
DNA Cell Biol; 2001 Apr; 20(4):189-202. PubMed ID: 11403716
[TBL] [Abstract][Full Text] [Related]
8. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells.
Lamkhioued B; Abdelilah SG; Hamid Q; Mansour N; Delespesse G; Renzi PM
J Immunol; 2003 Jan; 170(1):537-47. PubMed ID: 12496441
[TBL] [Abstract][Full Text] [Related]
9. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid enhances cell proliferation during eosinopoiesis through the CD44 surface antigen.
Hamann KJ; Dowling TL; Neeley SP; Grant JA; Leff AR
J Immunol; 1995 Apr; 154(8):4073-80. PubMed ID: 7535820
[TBL] [Abstract][Full Text] [Related]
11. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
Carlson M; Peterson C; Venge P
Allergy; 1993 Aug; 48(6):437-42. PubMed ID: 8238799
[TBL] [Abstract][Full Text] [Related]
12. Novel co-operation between eotaxin and substance-P in inducing eosinophil-derived neurotoxin release.
El-Shazly A; Ishikawa T
Mediators Inflamm; 1999; 8(3):177-9. PubMed ID: 10704057
[TBL] [Abstract][Full Text] [Related]
13. Human umbilical vein endothelial cells support interleukin-3- and interleukin-5-induced eosinophil differentiation from cord blood CD34+ cells.
Ochiai K; Omura M; Mochizuki A; Ito M; Tomioka H
Int Arch Allergy Immunol; 1999; 120 Suppl 1():2-6. PubMed ID: 10529593
[TBL] [Abstract][Full Text] [Related]
14. Increased response of blood eosinophils to various chemotactic agents in quiescent Crohn disease.
Denis MA; Louis R; Malaise M; Belaiche J; Louis E
Scand J Gastroenterol; 2001 Feb; 36(2):190-5. PubMed ID: 11252412
[TBL] [Abstract][Full Text] [Related]
15. Eosinophil differentiation of human umbilical cord mononuclear cells and prolonged survival of mature eosinophils by murine EL-4 thymoma cell conditioned medium.
Ten RM; Butterfield JH; Kita H; Weiler DA; Fischkoff S; Ishizaka T; Sanderson CJ; Gleich GJ
Cytokine; 1991 Jul; 3(4):350-9. PubMed ID: 1873484
[TBL] [Abstract][Full Text] [Related]
16. Growth and differentiation of eosinophils from human peripheral blood CD 34+ cells.
Shalit M
Allerg Immunol (Paris); 1997 Jan; 29(1):7-10. PubMed ID: 9025988
[TBL] [Abstract][Full Text] [Related]
17. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival.
Meng Q; Ying S; Corrigan CJ; Wakelin M; Assoufi B; Moqbel R; Kay AB
Allergy; 1997 Nov; 52(11):1095-101. PubMed ID: 9404561
[TBL] [Abstract][Full Text] [Related]
18. Expressions of Eotaxin-3, Interleukin-5, and Eosinophil-Derived Neurotoxin in Chronic Subdural Hematoma Fluids.
Kawaguchi R; Osuka K; Aoyama M; Miyachi S; Takayasu M
J Neurotrauma; 2018 Oct; 35(19):2242-2249. PubMed ID: 29764285
[TBL] [Abstract][Full Text] [Related]
19. Pimecrolimus reduces eosinophil activation associated with calcium mobilization.
Plager DA; Henke SA; Matsuwaki Y; Madaan A; Squillace DL; Dierkhising RA; Kita H
Int Arch Allergy Immunol; 2009; 149(2):119-26. PubMed ID: 19127068
[TBL] [Abstract][Full Text] [Related]
20. The roles of a Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation.
Kim CK; Kita H; Callaway Z; Kim HB; Choi J; Fujisawa T; Shin BM; Koh YY
Pediatr Allergy Immunol; 2010 Jun; 21(4 Pt 2):e697-704. PubMed ID: 20444156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
